Forecasts
Financial Statements
AI Powered Summary
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Ask AI
Consolidated Quarterly Results (in ₹ Crores)
View Standalone
View Standalone
Consolidated Profit Loss (in ₹ Crores)
View Standalone
View Standalone
Consolidated Balance Sheet (in ₹ Crores)
View Standalone
View Standalone
Consolidated Cash Flows (in ₹ Crores)
View Standalone
View Standalone
Projection
Documents
Investor Presentation
Q2 FY19
Investor Presentation
Q4 FY18
Investor Presentation
Q4 FY18
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY18
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY18
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY18
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY18
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY17
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Actions
AI Mode
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Ask AI


Frequently Asked Questions about Sunil Healthcare Ltd
Sunil Healthcare Ltd (SUNLOC) is currently trading at 67.95 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Sunil Healthcare Limited is a leading manufacturer of Empty Hard Gelatin Capsule Shells in India, known for high-quality production standards. The company has expanded significantly since its inception, increasing its capsule production capacity to 15 billion shells annually by 2021-22. Sunil Healthcare also ventured into the food business, under the 'Sunloc Foods' brand, focusing on nuts and edible items like cashews and pistachios. The company has established subsidiaries in the USA and Mexico to extend its market reach and capitalize on international demand. Sunil Healthcare's recognition as a 'Star Export House' by the government underscores its substantial export capabilities and market presence.
Over the past 52 weeks, Sunil Healthcare Ltd has traded between a low of ₹60.55 and a high of ₹88.70. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Sunil Healthcare Ltd has a market capitalization of approximately 64.60. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Sunil Healthcare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 24.44 and operates in the Healthcare sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 64.60 Cr, Sunil Healthcare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Sunil Healthcare Ltd operates in the Healthcare sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Sunil Healthcare Ltd is 24.44. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

